Search

everythinglearnresearchcommunity

for

Search:↓

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Glycoconjugates help heal hair follicles during skin repair.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Acne is caused by increased sebum, abnormal skin shedding, bacteria, and inflammation, not dirt; treatments vary from creams to antibiotics or isotretinoin, with severe cases needing a dermatologist's care.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.